Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1145]

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer...

Prof Arnaud Mejean - Paris Descartes University, Paris, France

Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer with focus on intermediate IMDC-risk population ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )

Enzalutamide as treatment for men with mHSPC who have received testosterone...

Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Enzalutamide as treatment for men with mHSPC who have received testosterone suppression ( Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

Enzalutamide improves survival for men with metastatic hormone-sensitive...

Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA

Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer ( Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA )

Comment: Using enzalutamide will allow patients to avoid chemotherapy and...

Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA

Comment: Using enzalutamide will allow patients to avoid chemotherapy and steroids improving quality of life ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA )

Treating bladder problems for ovarian cancer patients

Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK

Treating bladder problems for ovarian cancer patients ( Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK )

Filtering through the options: Renal considerations in disease management

Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK

Filtering through the options: Renal considerations in disease management ( Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK )

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private...

Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology

Dr Alex Asiimwe, EFPIA lead for PIONEER, discusses the unique public-private aspects of BD4BO ( Dr Alex Asiimwe - Director, BAYER AG, Medical affairs, Epidemiology )

Prof Anders Bjartell discusses the data sources and access of the PIONEER data...

Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden

Prof Anders Bjartell discusses the data sources and access of the PIONEER data models ( Prof Anders Bjartell - Skåne University Hospital, Malmö, Lund University, Sweden )

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s...

Dr Billy Franks - Astellas Pharma B.V.

Dr Billy Franks explains the importance of data analysis plans for PIONEER’s research questions ( Dr Billy Franks - Astellas Pharma B.V. )

Denis Horgan explains the importance of actively engaging policy makers in...

Denis Horgan - Executive Director, European Alliance for Personalised Medicine

Denis Horgan explains the importance of actively engaging policy makers in PIONEER ( Denis Horgan - Executive Director, European Alliance for Personalised Medicine )

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve...

Prof James N’Dow - Chairperson, European Association of Urology Guidelines...

Prof James N’Dow, Academic lead for PIONEER, reflects on the first twelve months of the project ( Prof James N’Dow - Chairperson, European Association of Urology Guidelines Office )

Louise Fullwood explains the legal and ethical issues around data privacy...

Louise Fullwood - Legal Director, Pinsent Masons

Louise Fullwood explains the legal and ethical issues around data privacy within PIONEER ( Louise Fullwood - Legal Director, Pinsent Masons )

More from ecancer